2019
DOI: 10.1007/s10616-018-0279-4
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of the hepatocyte-derived cell line BFH12 as an in vitro model for bovine biotransformation

Abstract: The knowledge of drug metabolising enzymes (DMEs) in cattle is rather limited. The capability of the bovine foetal hepatocyte-derived cell line BFH12 to serve as model for biotransformation was evaluated. Gene expression analysis of DMEs was performed by reverse transcription PCR (RT-PCR). The presence of efflux transporters was visualised by immunocytochemistry, and functional induction of cytochrome P450 (CYP) 1A was assessed by the ethoxyresorufin-O-deethylase (EROD) assay. The production of bile acids was … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
9
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(9 citation statements)
references
References 64 publications
0
9
0
Order By: Relevance
“…In established hepatic cell lines, the basal gene expression profiles, and the corresponding phenotype, may differ substantially from hepatocyte primary cultures, the gold standard for studying xenobiotics metabolism and toxicity [59]. As for the BFH12 cell line, a partial characterization of constitutive and inducible mRNA levels of foremost drug metabolizing enzymes and transporters has already been made [45,46]; however, no whole-transcriptomic data have been published so far. Assuming the metabolic competence of fetal hepatocytes is lower compared to that of adult liver cells, we opted for pre-treatment with an AHR agonist, i.e., PCB126, to increase the cell line metabolic competence, hence the responsiveness to AFB1.…”
Section: Preliminary Evaluations Of Bfh12 Responsiveness To Pcb126mentioning
confidence: 99%
See 1 more Smart Citation
“…In established hepatic cell lines, the basal gene expression profiles, and the corresponding phenotype, may differ substantially from hepatocyte primary cultures, the gold standard for studying xenobiotics metabolism and toxicity [59]. As for the BFH12 cell line, a partial characterization of constitutive and inducible mRNA levels of foremost drug metabolizing enzymes and transporters has already been made [45,46]; however, no whole-transcriptomic data have been published so far. Assuming the metabolic competence of fetal hepatocytes is lower compared to that of adult liver cells, we opted for pre-treatment with an AHR agonist, i.e., PCB126, to increase the cell line metabolic competence, hence the responsiveness to AFB1.…”
Section: Preliminary Evaluations Of Bfh12 Responsiveness To Pcb126mentioning
confidence: 99%
“…Based on these considerations, the aim of the present study was to assess in vitro the overall transcriptional changes (RNA-seq) caused by AFB1 in a bovine fetal hepatocyte-derived cell line (BFH12). This cell line constitutively expresses most cattle drug metabolizing enzymes and transporters [45,46], but its transcriptome has not been fully characterized so far. With the intent to have a greater response of the aforementioned in vitro model, cells were pre-treated with the co-planar polychlorinated biphenyl 3,3 ,4,4 ,5-pentachlorobiphenyl (PCB126), a known agonist of the aryl hydrocarbon receptor (AHR) [47].…”
Section: Introductionmentioning
confidence: 99%
“…Therefore, it has protective capacity to interrupt the absorption, permeability, and retention of the drugs. [ 45 ] Ligand along with hydroxychloroquine shows type III acute oral toxicity. Ligand HNP‐Hn‐HNPH 2 indicates good inhibitor for human ether‐a‐go‐go‐related gene (hERG) that can lead to short QT syndrome.…”
Section: Resultsmentioning
confidence: 99%
“…Immortalized bovine fetal hepatocytes (BFH-12, Cellosaurus accession CVCL_JQ51) were purchased from Dr. Herber Fuhrmann (University of Leipzig, Leipzig, Germany) and were grown in vented T75 flasks (cat# 25-209, Olympus Plastics, Genesee Scientific, San Diego, CA, USA) in Williams' E Medium (cat# A1217601, Gibco, Thermo Fisher Scientific, Waltham, MA, USA) containing 5% FBS, 1% penicillin/streptomycin, 1% GlutaMAX supplement (cat# 35050061, Gibco), 100 nM of dexamethasone (cat# AAA17590, Alfa Aesar, Haverhill, MA, USA), and 0.2 U/mL of insulin (cat# I6634, Sigma-Aldrich), at 37 • C, with 5% CO 2 . Culture media choices and environmental conditions reflect the protocols developed in the original publication [18]. Cells were cultured for at least 3 passages before the beginning of each experiment.…”
Section: Cell Culture and Treatmentsmentioning
confidence: 99%
“…Utilizing albumin-bound FA would be more representative of a physiological state; however, it is unclear whether physiological mechanisms for the uptake of albumin-bound FA (discussed in [6]) would be maintained in a cell culture model. Ultimately, our approach provides the greatest degree of response, and as such allows to determine individual differences with greater precision; (4) BFH-12 are hepatocytes isolated and established from bovine fetuses [18] and are likely not fully representative of adult bovine hepatocytes, since the liver of calves is still maturing after few weeks post-birth [45]. However, the model should be reliable in determining the relative difference in activation and the additive effects of various FA on PPAR activation.…”
Section: Limitations Of the Studymentioning
confidence: 99%